Overview
HYMACO is a monocentric, randomized comparative pilot study with a total duration of 25 months. The purpose of this study is to evaluate the effectiveness of autoHYpnosis by anchoring in the prevention of anxiety related to wearing the mask for radiotherapy of head and neck tumors.
60 patients will be randomized into 3 arms ARM A : Standard care ARM B : Autohypnosis ARM C : Musicotherapy This study is carried out during the first 5 radiotherapy sessions because this is decisive for the good progress of subsequent sessions
Eligibility
Inclusion Criteria:
- Age > or =18
- Patient to receive radiotherapy for a tumor of the head and neck, with a compression mask
- Patient who obtained a score equal to or greater than 56 on the STAI form Y-A questionnaire during the consultation with the radiotherapist before starting treatment
- Patient capable and willing to follow all study procedures in accordance with the protocol
- Patient who understood the study and gave informed consent
- Patient affiliated to a social security system
Exclusion Criteria:
- Contraindication to hypnosis: psychosis, schizophrenia
- Non-French speaking patient
- Significant hearing loss
- Pregnant woman, likely to be, or breastfeeding
- Persons deprived of their liberty or under guardianship (including guardianship)
- Inability to undergo medical monitoring of the trial for geographical, social or psychological reasons
- Patient who has already received radiotherapy to the head or neck with a compression mask